Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Stem Cells (Dayton, Ohio)|June 16, 2011
Brief report: a bioassay to identify primary human prostate cancer repopulating cellsRoxanne Toivanen, David M Berman, Hong Wang, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 6, 2010
Estrogen receptor-beta activated apoptosis in benign hyperplasia and cancer of the prostate is androgen independent and TNFalpha mediatedStephen J McPherson, Shirin Hussain, Preetika Balanathan, et al.
Nature Cell Biology|September 22, 2014
Single luminal epithelial progenitors can generate prostate organoids in cultureChee Wai Chua, Maho Shibata, Ming Lei, et al.
Molecular Oncology|July 24, 2025
Single-cell transcriptomics redefines focal neuroendocrine differentiation as a distinct prostate cancer pathologyRosalia Quezada Urban, Shivakumar Keerthikumar, Ashlee Clark, et al.
Cancer Discovery|April 16, 2017
Transdifferentiation as a Mechanism of Treatment Resistance in a Mouse Model of Castration-Resistant Prostate CancerMin Zou, Roxanne Toivanen, Antonina Mitrofanova, et al.
Nature Protocols|April 6, 2013
A preclinical xenograft model of prostate cancer using human tumorsMitchell G Lawrence, Renea A Taylor, Roxanne Toivanen, et al.
European Urology|August 27, 2014
Patient-derived xenografts reveal that intraductal carcinoma of the prostate is a prominent pathology in BRCA2 mutation carriers with prostate cancer and correlates with poor prognosisGail P Risbridger, Renea A Taylor, David Clouston, et al.
Oncotarget|May 13, 2015
Stromal androgen receptor regulates the composition of the microenvironment to influence prostate cancer outcomeDamien A Leach, Eleanor F Need, Roxanne Toivanen, et al.
Nature Communications|August 20, 2021
The MURAL collection of prostate cancer patient-derived xenografts enables discovery through preclinical models of uro-oncologyGail P Risbridger, Ashlee K Clark, Laura H Porter, et al.
European Urology|July 28, 2018
Patient-derived Models of Abiraterone- and Enzalutamide-resistant Prostate Cancer Reveal Sensitivity to Ribosome-directed TherapyMitchell G Lawrence, Daisuke Obinata, Shahneen Sandhu, et al.
Pageof 2